These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Parkinson's Disease-Associated Changes in the Expression of Neurotrophic Factors and their Receptors upon Neuronal Differentiation of Human Induced Pluripotent Stem Cells. Novosadova EV; Nenasheva VV; Makarova IV; Dolotov OV; Inozemtseva LS; Arsenyeva EL; Chernyshenko SV; Sultanov RI; Illarioshkin SN; Grivennikov IA; Tarantul VZ J Mol Neurosci; 2020 Apr; 70(4):514-521. PubMed ID: 31820346 [TBL] [Abstract][Full Text] [Related]
26. Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells. Oliveira LM; Falomir-Lockhart LJ; Botelho MG; Lin KH; Wales P; Koch JC; Gerhardt E; Taschenberger H; Outeiro TF; Lingor P; Schüle B; Arndt-Jovin DJ; Jovin TM Cell Death Dis; 2015 Nov; 6(11):e1994. PubMed ID: 26610207 [TBL] [Abstract][Full Text] [Related]
27. Impairment of proteasome and anti-oxidative pathways in the induced pluripotent stem cell model for sporadic Parkinson's disease. Chang KH; Lee-Chen GJ; Wu YR; Chen YJ; Lin JL; Li M; Chen IC; Lo YS; Wu HC; Chen CM Parkinsonism Relat Disord; 2016 Mar; 24():81-8. PubMed ID: 26797011 [TBL] [Abstract][Full Text] [Related]
28. Discordance in monozygotic Parkinson's disease twins - continuum or dichotomy? Balck A; Borsche M; Kasten M; Lohmann K; Seibler P; Brüggemann N; Klein C Ann Clin Transl Neurol; 2019 Jun; 6(6):1102-1105. PubMed ID: 31211174 [TBL] [Abstract][Full Text] [Related]
29. Parkinson's disease in a dish - Using stem cells as a molecular tool. Badger JL; Cordero-Llana O; Hartfield EM; Wade-Martins R Neuropharmacology; 2014 Jan; 76 Pt A():88-96. PubMed ID: 24035919 [TBL] [Abstract][Full Text] [Related]
35. Gene co-expression network analysis for identifying genetic markers in Parkinson's disease - a three-way comparative approach. George G; Singh S; Lokappa SB; Varkey J Genomics; 2019 Jul; 111(4):819-830. PubMed ID: 29852216 [TBL] [Abstract][Full Text] [Related]
36. Understanding Parkinson's Disease through the Use of Cell Reprogramming. Playne R; Connor B Stem Cell Rev Rep; 2017 Apr; 13(2):151-169. PubMed ID: 28083784 [TBL] [Abstract][Full Text] [Related]
37. Decoding Parkinson's disease - iPSC-derived models in the OMICs era. Krach F; Bogiongko ME; Winner B Mol Cell Neurosci; 2020 Jul; 106():103501. PubMed ID: 32439399 [TBL] [Abstract][Full Text] [Related]
38. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases. Pan-Montojo F; Funk RH CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153 [TBL] [Abstract][Full Text] [Related]
39. Endosomal dysfunction in iPSC-derived neural cells from Parkinson's disease patients with VPS35 D620N. Bono K; Hara-Miyauchi C; Sumi S; Oka H; Iguchi Y; Okano HJ Mol Brain; 2020 Oct; 13(1):137. PubMed ID: 33032646 [TBL] [Abstract][Full Text] [Related]
40. Overexpression of Parkin in the Neuronal Progenitor Cells from a Patient with Parkinson's Disease Shifts the Transcriptome Towards the Normal State. Lebedeva O; Poberezhniy D; Novosadova E; Gerasimova T; Novosadova L; Arsenyeva E; Stepanenko E; Shimchenko D; Volovikov E; Anufrieva K; Illarioshkin S; Lagarkova M; Grivennikov I; Tarantul V; Nenasheva V Mol Neurobiol; 2023 Jun; 60(6):3522-3533. PubMed ID: 36884134 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]